People | Page 435 of 525 | SpiritIndia.com

Ulcerative Colitis :: Adherence to ulcerative colitis medications is not affected by drug formulation or dosing regimen

Poor adherence to medication is a recognized medical problem, costing an estimated $100 billion a year in the United States.(i) New data show that while there is a steady decline in adherence to medications for ulcerative colitis (UC), drug formulation and the number of pills taken each day do not affect long-term adherence. The data were presented today at the annual scientific meeting of the American College of Gastroenterology by University of Chicago researcher Sunanda Kane, M.D.

Health :: Millstone Coffee Expands Flavored Offerings with Introduction of New Cinnamon Gingerbread

Believe it or not, the holiday season is just around the corner. Before you know it, the streets will be bustling with shoppers, malls will be donned with holiday decor, and the sounds of the season will be echoing through your ears — bringing with them the anticipation of seeing family and friends once again for a season filled with good times, good memories, and great holiday foods.

Herpes :: Merck’s shingles vaccine Zostavax, Zoster Vaccine Live for herpes zoster

Merck & Co., Inc. announced that the U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) voted unanimously to recommend that adults 60 years of age and older be vaccinated with ZOSTAVAX? [Zoster Vaccine Live (Oka/Merck)] to help prevent shingles (herpes zoster), a frequently painful disease marked by a blistering rash.

Health :: Bayer HealthCare acquires western OTC cough & cold business of Topsun Science and Technology

Bayer HealthCare (BHC) and Topsun Science and Technology Co., Ltd. (Topsun, 600771.SS) together announced that BHC’s Consumer Care Division has signed an agreement in China to acquire the Western over-the-counter (OTC) cough and cold portfolio of Topsun Science and Technology Qidong Gaitianli Pharmaceutical Co., Ltd. for the consideration of RMB 1,072 million (approximately EUR 103 million) plus contingent payments of RMB 192 million (approximately EUR 19 million) subject to fulfilment of certain performance criteria.

Hepatitis :: Tyzeka, Sebivo or telbivudine for patients with chronic hepatitis B – Novartis

Novartis announced the US regulatory approval of Tyzeka(TM) (telbivudine) as a new once-a-day oral treatment for patients with chronic hepatitis B, a disease estimated to affect about 1.25 million people in the US but more than 350 million globally and considered the tenth leading cause of death.

HIV :: Most HIV infected individuals with inadequate outpatient medical care

In a first-of-its-kind study, UCLA researchers have shown that segments of the HIV-infected population who have little to no consistent outpatient medical care ? and yet are most in need of such services ? are overwhelmingly minorities, the poor and substance abusers.

Crohn’s Disease :: Promising results in tough-to-treat crohn’s disease patients

Abbott announced results from a study showing HUMIRA? (adalimumab) induced significantly higher rates of clinical remission compared to placebo in patients with moderately to severely active Crohn’s disease who lost response to, or were intolerant to, infliximab therapy. The data is being presented simultaneously at the American College of Gastroenterology (ACG) annual meeting in Las Vegas and the United European Gastroenterology Week (UEGW) in Berlin.

Tuberculosis :: Testing and diagnosis process not adequate

Most of the nine million people who fall ill with tuberculosis each year lack access to adequate testing and diagnosis, complicating efforts to stop its spread, the World Health Organisation (WHO) said. The United Nations agency said big investments were needed to develop diagnostics in low and middle income countries, where three-quarters of screenings take place for the respiratory system disease which claims 1.7 million lives a year.

Diet :: Trial aims to find out which diets work

A new Australian clinical trial hopes to answer the question about which diets work and why. Healthy volunteers will be kept in controlled laboratory conditions for a week and fed diets with different levels of protein.

Asthma :: Exposure to sunlight could reduce asthma

Australian researchers have found that exposure to measured doses of ultraviolet light, such as sunlight, could reduce asthma. The research team at Perth’s Telethon Institute for Child Health Research, through funding provided by the Asthma Foundation of WA, studied the effect of ultraviolet light on the development of asthma-like symptoms in mice, such as inflamed airways and lungs.